PHH2 Stock Overview
Manufactures and sells medical and care products in Germany, rest of Europe, the Middle East, Africa, Asia and Pacific region, and the Americas. More details
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 0/6 |
| Past Performance | 4/6 |
| Financial Health | 5/6 |
| Dividends | 5/6 |
My Notes
Capture your thoughts, links and company narrative
Paul Hartmann AG Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €222.00 |
| 52 Week High | €244.00 |
| 52 Week Low | €183.00 |
| Beta | 0.45 |
| 1 Month Change | 6.22% |
| 3 Month Change | 13.27% |
| 1 Year Change | 10.45% |
| 3 Year Change | -33.53% |
| 5 Year Change | -23.45% |
| Change since IPO | 86.20% |
Recent News & Updates
Paul Hartmann's (FRA:PHH2) Problems Go Beyond Weak Profit
Mar 25
Calculating The Fair Value Of Paul Hartmann AG (FRA:PHH2)
Mar 08Recent updates
Paul Hartmann's (FRA:PHH2) Problems Go Beyond Weak Profit
Mar 25Calculating The Fair Value Of Paul Hartmann AG (FRA:PHH2)
Mar 08Getting In Cheap On Paul Hartmann AG (FRA:PHH2) Is Unlikely
Jan 31Paul Hartmann (FRA:PHH2) Has A Somewhat Strained Balance Sheet
Nov 16The Returns On Capital At Paul Hartmann (FRA:PHH2) Don't Inspire Confidence
Jul 05Is Paul Hartmann (FRA:PHH2) A Risky Investment?
May 06Paul Hartmann's (FRA:PHH2) Returns On Capital Not Reflecting Well On The Business
Jan 07Here's What's Concerning About Paul Hartmann's (FRA:PHH2) Returns On Capital
Sep 03Here's Why Paul Hartmann (FRA:PHH2) Can Manage Its Debt Responsibly
Apr 02Paul Hartmann (FRA:PHH2) Shareholders Will Want The ROCE Trajectory To Continue
Mar 09Is Paul Hartmann (FRA:PHH2) Using Too Much Debt?
Nov 24There's Been No Shortage Of Growth Recently For Paul Hartmann's (FRA:PHH2) Returns On Capital
May 19We Think Paul Hartmann (FRA:PHH2) Can Manage Its Debt With Ease
Apr 12Should You Buy Paul Hartmann AG (FRA:PHH2) For Its Dividend?
Mar 25Does Paul Hartmann's (FRA:PHH2) Share Price Gain of 29% Match Its Business Performance?
Feb 24Paul Hartmann AG's (FRA:PHH2) Stock Has Seen Strong Momentum: Does That Call For Deeper Study Of Its Financial Prospects?
Feb 03We're Watching These Trends At Paul Hartmann (FRA:PHH2)
Dec 29
How Does Paul Hartmann AG (FRA:PHH2) Fare As A Dividend Stock?
Dec 11If You Had Bought Paul Hartmann's (FRA:PHH2) Shares Three Years Ago You Would Be Down 16%
Nov 23Shareholder Returns
| PHH2 | DE Medical Equipment | DE Market | |
|---|---|---|---|
| 7D | 2.8% | -2.9% | -2.6% |
| 1Y | 10.4% | -8.5% | 6.9% |
Return vs Industry: PHH2 exceeded the German Medical Equipment industry which returned -8.5% over the past year.
Return vs Market: PHH2 exceeded the German Market which returned 6.9% over the past year.
Price Volatility
| PHH2 volatility | |
|---|---|
| PHH2 Average Weekly Movement | 4.3% |
| Medical Equipment Industry Average Movement | 6.6% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 11.2% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: PHH2 has not had significant price volatility in the past 3 months compared to the German market.
Volatility Over Time: PHH2's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1818 | 10,045 | Britta Fuenfstueck | hartmann.info |
Paul Hartmann AG manufactures and sells medical and care products in Germany, rest of Europe, the Middle East, Africa, Asia and Pacific region, and the Americas. The company operates through three segments: Incontinence Management, Wound Care, and Infection Management. It offers body-absorbent products and traditional and modern wound dressings.
Paul Hartmann AG Fundamentals Summary
| PHH2 fundamental statistics | |
|---|---|
| Market cap | €788.49m |
| Earnings (TTM) | €59.53m |
| Revenue (TTM) | €2.40b |
13.2x
P/E Ratio0.3x
P/S RatioIs PHH2 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| PHH2 income statement (TTM) | |
|---|---|
| Revenue | €2.40b |
| Cost of Revenue | €1.05b |
| Gross Profit | €1.34b |
| Other Expenses | €1.28b |
| Earnings | €59.53m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 16.76 |
| Gross Margin | 56.03% |
| Net Profit Margin | 2.48% |
| Debt/Equity Ratio | 26.3% |
How did PHH2 perform over the long term?
See historical performance and comparisonDividends
3.6%
Current Dividend Yield48%
Payout RatioCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/22 02:15 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | 2024/06/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Paul Hartmann AG is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|